Represented a national company offering healthcare solutions and tech-enabled services in its continued investment into, and purchase of preferred stock of an early stage technology platform for healthcare providers to access medical data, research, and studies in a digestible format. Our corporate investor client previously invested in the company through a number of simple agreements for future equity (SAFEs) that also converted into preferred stock.